ptld
- 网络移植后淋巴组织增生性疾病;淋巴组织增生性疾病;移植后淋巴增生性疾病;移植后淋巴细胞增殖性疾病;淋巴细胞增殖性疾病
ptld-
The duration between organ transplantation and diagnosis of PTLD from case 1 to case 4 was 42,7,129,2 months .
例1~4从移植到诊断PTLD的时间为42、7、129、2个月。
-
The majority of PTLD originates from malignant proliferation of B-cell .
大多数PTLD起源于B细胞单克隆恶性增殖。
-
PTLD has low incidence , poor prognosis . Treatment should be taken to improve the prognosis of patients and prolong survival period .
PTLD发病率低，预后差，采取积极治疗有望改善患者预后，延长生存期。
-
Recenly , the incidence of posttransplatation lymphoproliferative disorder ( PTLD ) is rising , Immunodeficiency and EBV-infection are risk factors of pathogenesis related .
近年来，移植后淋巴组织增生性疾病（PTLD）的发病率呈上升趋势，其发病危险因素与免疫缺陷、EBV感染有关。